|
RPLP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.091200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.565400E-01 |
| Normal-vs-Stage2 |
5.790800E-01 |
| Normal-vs-Stage3 |
8.666300E-02 |
| Normal-vs-Stage4 |
2.845800E-02 |
| Stage1-vs-Stage2 |
1.577180E-01 |
| Stage1-vs-Stage3 |
3.069400E-01 |
| Stage1-vs-Stage4 |
1.229400E-01 |
| Stage2-vs-Stage3 |
6.524200E-02 |
| Stage2-vs-Stage4 |
2.824400E-02 |
| Stage3-vs-Stage4 |
5.034400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.160100E-02 |
| Normal-vs-AfricanAmerican |
8.785800E-01 |
| Normal-vs-Asian |
6.896100E-02 |
| Caucasian-vs-AfricanAmerican |
2.979200E-01 |
| Caucasian-vs-Asian |
3.549400E-01 |
| AfricanAmerican-vs-Asian |
1.347800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.274100E-02 |
| Normal-vs-Female |
3.541200E-01 |
| Male-vs-Female |
1.249610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.331250E-01 |
| Normal-vs-Age(41-60Yrs) |
2.384200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.387800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.524000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.298600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.728400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.988600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.650400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.775600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.933200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.332200E-01 |
| Classical-VS-Follicular |
3.77959999999788E-05 |
| Classical-VS-Other |
8.731600E-01 |
| Classical-VS-Normal |
7.383700E-02 |
| Tall-VS-Follicular |
2.123000E-03 |
| Tall-VS-Other |
7.005200E-01 |
| Tall-VS-Normal |
3.188000E-02 |
| Follicular-VS-Other |
1.787230E-01 |
| Follicular-VS-Normal |
1.814780E-01 |
| Other-VS-Normal |
3.654400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.477600E-01 |
| Normal-vs-N1 |
6.094400E-02 |
| N0-vs-N1 |
2.157400E-01 |
|
|
